SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549



FORM 8-K


CURRENT REPORT



Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934



Date of Report (Date of earliest event reported): January 5, 2011



BioMedical Technology Solutions Holdings, Inc.

(Exact name of registrant as specified in its charter)



             Colorado              

____000-52652___

        26-3161860        

(State or other jurisdiction of

incorporation or organization)

(Commission

file number)

(IRS Employer

Identification No.)


9800 Mt Pyramid Court # 250

            Englewood, CO  80112            
(Address of principal executive offices)    (Zip Code)


Registrant's telephone number, including area code:  (303) 653-0100



______________________________________________________

(Former name or former address, if changed since last report)




___

Written communications pursuant to Rule 425 under the Securities Act

___

Soliciting material pursuant to Rule 14a-12 under the Exchange Act

___

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

___

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act





ITEM 5.02

DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION



OF DIRECTOR; APPOINTMENT OF CERTAIN OFFICERS;

COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS


       

Effective January 5, 2011, Donald G. Cox voluntarily tendered his resignation as a member of the Board of Directors, and as a member of the Nominating, Auditing and Compensation Committees of BioMedical Technology Solutions Holdings, Inc.  The resignation is effective immediately.


Also effective January 5, 2011, Danielle Kettunen voluntarily tendered her resignation as Corporate Secretary of BioMedical Technology Solutions Holdings, Inc.  The resignation is effective immediately.



SIGNATURE


        Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



  

BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS, INC.


Date:   January 7, 2011

By: ___/s/ Donald G. Cox__________

     Donald G. Cox, President

  




2